Summit Trail Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82M Buy
15,215
+2,364
+18% +$310K 0.03% 598
2025
Q4
$1.75M Buy
12,851
+1,774
+16% +$255K 0.03% 490
2025
Q3
$1.63M Buy
11,077
+8,201
+285% +$1.14M 0.02% 549
2025
Q2
$372K Buy
+2,876
New +$348K 0.01% 834
2018
Q1
Sell
-113
Closed -$8K 1693
2017
Q4
$8K Buy
+113
New +$7.5K ﹤0.01% 1290

Other funds holding XYL

Summit Trail Advisors's XYL Position: Q1 2026 in Review

Summit Trail Advisors increased its Xylem (XYL) stake by 18% in Q1 2026, buying an estimated $310K and bringing the position to 15,215 shares worth $1.82M. The position accounts for 0.03% of the portfolio, ranked #598.

Summit Trail Advisors first reported a position in XYL in Q4 2017 and has held it in 5 quarters since. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Summit Trail Advisors held 15,215 shares of Xylem worth $1.82M as of Q1 2026.
  • Summit Trail Advisors bought 2,364 Xylem shares in Q1 2026, an estimated $310K.
  • Xylem made up 0.03% of Summit Trail Advisors's portfolio in Q1 2026, its #598 holding.
  • Summit Trail Advisors first reported a position in Xylem in Q4 2017 and has held it in 5 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.